- Home
- CUE vs HKIT Comparison
CUE vs HKIT Comparison
Compare CUE & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- HKIT
- Stock Information
- Founded
- CUE 2014
- HKIT 1996
- Country
- CUE United States
- HKIT China
- Employees
- CUE N/A
- HKIT N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- HKIT Computer Software: Prepackaged Software
- Sector
- CUE Health Care
- HKIT Technology
- Exchange
- CUE Nasdaq
- HKIT Nasdaq
- Market Cap
- CUE 61.1M
- HKIT 54.8M
- IPO Year
- CUE 2018
- HKIT 2023
- Fundamental
- Price
- CUE $0.70
- HKIT $2.06
- Analyst Decision
- CUE Strong Buy
- HKIT
- Analyst Count
- CUE 2
- HKIT 0
- Target Price
- CUE $3.00
- HKIT N/A
- AVG Volume (30 Days)
- CUE 270.3K
- HKIT 40.8K
- Earning Date
- CUE 11-12-2025
- HKIT 04-08-2026
- Dividend Yield
- CUE N/A
- HKIT N/A
- EPS Growth
- CUE N/A
- HKIT N/A
- EPS
- CUE N/A
- HKIT N/A
- Revenue
- CUE $8,286,000.00
- HKIT $1,812,901.00
- Revenue This Year
- CUE N/A
- HKIT N/A
- Revenue Next Year
- CUE N/A
- HKIT N/A
- P/E Ratio
- CUE N/A
- HKIT N/A
- Revenue Growth
- CUE N/A
- HKIT N/A
- 52 Week Low
- CUE $0.54
- HKIT $1.15
- 52 Week High
- CUE $1.99
- HKIT $2.41
- Technical
- Relative Strength Index (RSI)
- CUE 38.97
- HKIT 58.36
- Support Level
- CUE $0.76
- HKIT $2.00
- Resistance Level
- CUE $0.81
- HKIT $2.41
- Average True Range (ATR)
- CUE 0.05
- HKIT 0.16
- MACD
- CUE -0.01
- HKIT 0.01
- Stochastic Oscillator
- CUE 10.92
- HKIT 42.46
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.